Oncimmune Holdings plc (LON:ONC – Get Free Report)’s share price reached a new 52-week low on Wednesday . The company traded as low as GBX 8 ($0.10) and last traded at GBX 9.95 ($0.12), with a volume of 378794 shares traded. The stock had previously closed at GBX 10.20 ($0.13).
Oncimmune Trading Up 4.9 %
The company has a 50 day moving average of GBX 13.59 and a two-hundred day moving average of GBX 14.82. The stock has a market capitalization of £7.19 million, a PE ratio of -323.40 and a beta of 1.19. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 1.13.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Recommended Stories
- Five stocks we like better than Oncimmune
- The Risks of Owning Bonds
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Makes a Stock a Good Dividend Stock?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Stock Analyst Ratings and Canadian Analyst Ratings
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
